Keyphrases
COVID-19
100%
Linezolid
45%
Neutralizing Antibodies
27%
Patients with COVID-19
25%
Viral Load
25%
Thrombocytopenia
24%
Methicillin-resistant Staphylococcus Aureus
21%
Daptomycin
21%
Staphylococcus Aureus Bacteremia
18%
Quantitative PCR
17%
Nasopharyngeal Viral Load
16%
Neutralizing Activity
16%
Pseudotyped Virus
15%
Japan
15%
Dosing Regimen
15%
Type I Interferon
14%
Respiratory Failure
14%
Omicron Variant
14%
RNAemia
13%
Therapeutic Drug Monitoring
12%
Favipiravir
11%
Bacteremia
11%
Clinical Characteristics
11%
SARS-CoV-2 Variants
10%
Acute Phase
10%
SARS-CoV-2 Infection
10%
Hospitalized Patients
10%
Retrospective Cohort Study
10%
SARS-CoV-2 Neutralizing Antibody
9%
Pharmacodynamics
8%
Disease Severity
8%
Domain Antibody
8%
Receptor-binding Domain
8%
University Hospital
8%
Viral Clearance
8%
Neutralization Test
8%
Chemiluminescence
8%
SARS-CoV-2 Spike Protein
8%
Vancomycin
8%
Vesicular Stomatitis Virus
8%
CXCL10
8%
Nosocomial Infection
7%
Interleukin-6
7%
Cmin
7%
Omicron BA.5
7%
Antibody Level
7%
Antireceptor
7%
Pharmacokinetics
7%
Serum Samples
7%
Symptomatic Patients
7%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
62%
Infection
55%
Linezolid
45%
Thrombocytopenia
24%
Coronavirinae
24%
Neutralizing Antibody
21%
Daptomycin
20%
Pharmacokinetics
18%
Methicillin Resistant Staphylococcus Aureus Infection
18%
Disease
16%
Cohort Study
16%
Pharmacodynamics
14%
Interferon Type I
14%
Respiratory Failure
14%
Methicillin-Resistant Staphylococcus Aureus
14%
Favipiravir
12%
Hemodialysis
11%
Therapeutic Drug Monitoring
11%
Fatality
10%
Interleukin 6
10%
Randomized Controlled Trial
8%
Bloodstream Infection
8%
Viral Clearance
8%
Interferon
8%
Vesiculovirus
8%
Vancomycin
7%
Hospital Infection
7%
Virus Infectivity
7%
Hyponatremia
7%
Drug Fever
7%
Hamster Model
7%
Disease Severity
7%
Teicoplanin
7%
Congenital Tuberculosis
7%
Provocation Test
7%
Respiratory Tract Infection
7%
Prematurity
7%
Endocarditis
7%
Cmin
6%
Bacterial Endocarditis
6%
Hypoxemia
5%
Medicine and Dentistry
COVID-19
52%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Infection
18%
Bloodstream Infection
15%
Respiratory Failure
14%
Abscess
10%
Interleukin 6
10%
Reverse Transcription Polymerase Chain Reaction
9%
Interferon
8%
Cohort Study
7%
Interferon Type I
7%
Hypertranslucent Lung
7%
Multimodal Imaging
7%
Disease Severity
7%
Congenital Tuberculosis
7%
Nocardia
7%
Hospital Infection
7%
Viral Clearance
7%
Prematurity
7%
Respiratory Tract Infection
7%
Extracorporeal
7%
Decision Making
7%
Computer Assisted Tomography
7%
Omicron Coronavirus Variant
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Lung
5%